Lot-to-lot consistency, immunogenicity, and safety of a 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy adults aged 40-65 years: A randomized, double-blind, controlled, phase IV clinical trial
23价肺炎球菌多糖疫苗(PPV23)在40-65岁健康成人中的批间一致性、免疫原性和安全性:一项随机、双盲、对照的IV期临床试验
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2025.2579366
Zhang, Yunong; Shi, Gang; Zhou, Siliang; Zhao, Weimin; Wang, Lianhao; Li, Jidong; Zhao, Zhifeng; Li, Gaimei; Geng, Jiaxu; Chen, Zhuozhuo; Zhao, Haiyan; Li, Yun; Xu, Li; Wang, Bin; Jiao, Peng; Li, Guohua